March 18, 2024Med-tech gainers and losers for March 11-15, 2024The top 10 med-tech stock gainers and losers for the week.
March 18, 2024Regulatory actions for March 18, 2024Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Bristol Myers Squibb, Immvira, Madrigal.